{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antibacterial", "Efflux pump inhibitor", "Membrane disruption", "Natural products", "Proton motive force"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30380450", "DateCompleted": {"Year": "2020", "Month": "01", "Day": "07"}, "DateRevised": {"Year": "2020", "Month": "01", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bioorg.2018.10.024", "S0045-2068(18)30813-7"], "Journal": {"ISSN": "1090-2120", "JournalIssue": {"Volume": "83", "PubDate": {"Year": "2019", "Month": "Mar"}}, "Title": "Bioorganic chemistry", "ISOAbbreviation": "Bioorg Chem"}, "ArticleTitle": "A novel bi-functional chalcone inhibits multi-drug resistant Staphylococcus aureus and potentiates the activity of fluoroquinolones.", "Pagination": {"StartPage": "214", "EndPage": "225", "MedlinePgn": "214-225"}, "Abstract": {"AbstractText": ["Staphylococcus aureus is the leading cause of bacteraemia and the dwindling supply of effective antibacterials has exacerbated the problem of managing infections caused by this bacterium. Isoliquiritigenin (ISL) is a plant flavonoid that displays therapeutic potential against S. aureus. The present study identified a novel mannich base derivatives of ISL, IMRG4, active against Vancomycin intermediate S. aureus (VISA). IMRG4 damages the bacterial membranes causing membrane depolarization and permeabilization, as determined by loss of salt tolerance, flow cytometric analysis, propidium idodie and fluorescent microscopy. It reduces the intracellular invasion of HEK-293 cells by S. aureus and decreases the staphylococcal load in different organs of infected mice models. In addition to anti-staphylococcal activity, IMRG4 inhibits the multidrug efflux pump, NorA, which was determined by molecular docking and EtBr efflux assays. In combination, IMRG4 significantly reduces the MIC of norfloxacin for clinical strains of S. aureus including VISA. Development of resistance against IMRG4 alone and in combination with norfloxacin was low and IMRG4 prolongs the post-antibiotic effect of norfloxacin. These virtues combined with the low toxicity of IMRG4, assessed by MTT assay and haemolysis, makes it an ideal candidate to enter drug development pipeline against S. aureus."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bacteriology and Chemical Genetics Lab, Department of Biotechnology, Indian Institute of Technology Roorkee, District Haridwar, Uttarakhand 247667, India."}], "LastName": "Gupta", "ForeName": "Vivek Kumar", "Initials": "VK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India."}], "LastName": "Gaur", "ForeName": "Rashmi", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bacteriology and Chemical Genetics Lab, Department of Biotechnology, Indian Institute of Technology Roorkee, District Haridwar, Uttarakhand 247667, India."}], "LastName": "Sharma", "ForeName": "Atin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bacteriology and Chemical Genetics Lab, Department of Biotechnology, Indian Institute of Technology Roorkee, District Haridwar, Uttarakhand 247667, India."}], "LastName": "Akther", "ForeName": "Jawed", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bacteriology and Chemical Genetics Lab, Department of Biotechnology, Indian Institute of Technology Roorkee, District Haridwar, Uttarakhand 247667, India."}], "LastName": "Saini", "ForeName": "Mahak", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India."}], "LastName": "Bhakuni", "ForeName": "Rajendra Singh", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bacteriology and Chemical Genetics Lab, Department of Biotechnology, Indian Institute of Technology Roorkee, District Haridwar, Uttarakhand 247667, India. Electronic address: rpathfbs@iitr.ac.in."}], "LastName": "Pathania", "ForeName": "Ranjana", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioorg Chem", "NlmUniqueID": "1303703", "ISSNLinking": "0045-2068"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Bacterial Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Fluoroquinolones"}, {"RegistryNumber": "0", "NameOfSubstance": "Multidrug Resistance-Associated Proteins"}, {"RegistryNumber": "133135-40-7", "NameOfSubstance": "NorA protein, Staphylococcus"}, {"RegistryNumber": "N0F8P22L1P", "NameOfSubstance": "Norfloxacin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology", "toxicity"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Bacterial Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Adhesion"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Membrane"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Membrane Permeability"}, {"QualifierName": ["chemical synthesis", "pharmacology", "toxicity"], "DescriptorName": "Chalcones"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Bacterial"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemical synthesis", "pharmacology", "toxicity"], "DescriptorName": "Fluoroquinolones"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Methicillin-Resistant Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Multidrug Resistance-Associated Proteins"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Norfloxacin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "8", "Day": "6"}, {"Year": "2018", "Month": "10", "Day": "10"}, {"Year": "2018", "Month": "10", "Day": "11"}, {"Year": "2018", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30380450", "10.1016/j.bioorg.2018.10.024", "S0045-2068(18)30813-7"]}}]}